Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 May 3.
Published in final edited form as: Bone Marrow Transplant. 2017 Jun 26;52(9):1338–1341. doi: 10.1038/bmt.2017.124

Parent versus Child Donor Perceptions of the Bone Marrow Donation Experience

Galen E Switzer 1,2,3,4, Jessica Bruce 2, Gabrielle Pastorek 2, Deidre M Kiefer 5, Hati Kobusingye 5, Rebecca Drexler 5, RaeAnne M Besser 5, Dennis L Confer 5, Mary M Horowitz 6, Roberta J King 5, Bronwen E Shaw 6, Suzanna M van Walraven 7,8, Lori Wiener 9, Wendy Packman 10, James W Varni 11,12, Michael A Pulsipher 13
PMCID: PMC5933883  NIHMSID: NIHMS961496  PMID: 28650449

Although the use of minors as HSC donors is considered medically safe4 and legally acceptable given that no alternative approach of comparable effectiveness exists, several published literature reviews and national organizations like the American Academy of Pediatrics have noted a lack of understanding of the physical/psychosocial effects of pediatric HSC donation and have called for investigations of such effects.5,6,7,8,9

Prior to our recently completed investigation of health-related quality-of-life (HRQoL) in sibling pediatric HSC donation (RDSafe: A Multi-Institutional Study of HSC Donor Safety and Quality Life), the few reviews and other published investigations of pediatric HSC donors' experiences indicated that pediatric donors might experience a variety of psychosocial issues around donation – but limitations in prior investigations prevented definitive conclusions.6,7,8,9,10,11,12

Key findings from our own RDSafe study – which interviewed donors and their parents/guardians at pre-donation and at 4-weeks and 1-year post-donation – included:(1) ∼20% of donors at each time point had very poor HRQoL, (2) child self-reported HRQoL was significantly lower than parent proxy-reported HRQoL and significantly lower than that of health normative comparison children, and (3) younger children (ages 5-7) were at particular risk of poor HRQoL.18

The goals of this follow-up analysis were to (1) examine whether parents of donor children believed that their child's age made a difference in donation-related experiences, (2) determine whether donor, recipient, or family characteristics differed by whether or not parents believed that their child's age made a difference, (3) qualitatively examine how parents explained the effects of their child's age, and (4) determine whether parents characterized their child's donation experience differently depending on whether their child self-reported very poor HRQoL.

This study was approved by IRBs at the University of Pittsburgh, the National Marrow Donor Program (NMDP), and participating transplant centers. Parents signed informed consent and children gave assent. The study included randomly selected pediatric sibling HSC donors aged 5-18 who were first-time bone marrow or PBSC donors in the US between April, 2010 and May, 2013 and their parent/guardian.

Pediatric donors and parents completed telephone interviews in English four weeks pre-donation and 4-weeks and 1-year post-donation. See Switzer et al., for additional methodological details.18 Measures included: (1) socio-demographics, (2) donor HRQoL assessed with the PedsQL™ 4.0 Generic Core Scales with both child and parent independent reports on child donor HRQoL,19-21 and (3) parents' beliefs about the effects of their child's age assessed with a question asking whether they believed that their child's age made a difference in his/her donation experience (yes, no), and, if yes, how they believed that age affected the child's experience of the process (open-ended). The PedsQL™ is scored 0-100 with higher scores indicating better HRQoL. An “at risk” cutoff score of ≤ 69.71 is defined by the PedsQL™ developers.21 Children scoring at or below this cutoff have HRQoL similar to that of chronically ill children.19-21

See Switzer et al. for descriptive statistics on socio-demographics and HRQoL for the entire sample.18 Socio-demographic comparisons of parents who reported that their child's age made a difference versus not and comparisons of children with HRQoL scores above versus below the at-risk cutoff were performed using t-tests and chi-square tests as appropriate. Qualitative data from parent responses to the open-ended question were reviewed for themes by three co-authors (GES, JB, and GP) and independently coded by two coders (GES and GP). Any coding disagreements were coded by a third co-author (JB) and adjudicated during group discussion.

This analysis includes 102 donor/parent pairs who completed both the pre-donation and 4-weeks post-donation interviews and 94 pairs who completed pre- and 1-year post-donation interviews. The majority of donors (93%) donated bone marrow and 7% donated PBSC.

At 4-weeks post-donation, 95/102 parents answered the question about their donor child's age making a difference (yes/no) – of those, 80% indicated that they believed their child's age made a difference in the donation experience. At 1-year post-donation, 89/94 parents answered the question – of those, 81% indicated that they believed their child's age made a difference in the donation experience.

Table 1 compares the two groups of parents (yes/no) by donor, recipient, and parent/family characteristics. At 4-weeks post-donation, parents of younger, male, and white donors; parents of younger recipients; and families with higher incomes were significantly more likely to indicate that their child's age made a difference. At 1-year post-donation, the pattern of results was similar but not statistically significant.

Table 1.

Participant characteristics by parents' beliefs about the effects of donor age at 4-weeks and 1–year post-donation.

Characteristic 4-weeks Post-donation 1-year Post-donation
Yes n=76 No n=19 X2 or t p Yes n=72 No n=17 X2 or t p
Demographic
Donor
Age group (%) 5.90 0.05 2.71 0.26
 5-7 100 0 94 6
 8-12 80 20 82 18
 13-17 72 28 74 26
Sex (%) 6.18 0.01 0.38 0.54
 Male 89 11 83 17
 Female 68 32 78 22
Ethnicity (%) 8.85 0.03 6.15 0.09
 White 90 10 89 11
 Black 65 35 63 37
 Hispanic 75 25 75 25
 Other 57 43 86 14
Relationship to recipient (%) 4.55 0.47 6.93 0.23
 Recipient is older brother 84 16 71 29
 Recipientis younger brother 80 20 91 9
 Recipient is older sister 84 16 72 23
 Recipientis younger sister 78 22 82 18
 Recipient is twin 75 25 50 50
Recipient
Age, mean (sd) 10.3 (5.5) 14.3 (7.6) -2.16 0.04 10.9 (3.5) 12.2 (3.4) -1.43 0.16
Sex (%) 0.04 0.83 0.53 0.47
 Male 79 21 83 17
 Female 81 19 77 23
Parent/Guardian
Respondent relationship to donor (%) 4.10 0.12 1.01 0.61
 Mother 81 19 83 17
 Father 79 21 74 26
 Other 0 100 100 0
Age, mean (sd) 40.3 (6.9) 43.4 (9.4) -1.60 0.11 40.0 (7.5) 41.4 (6.0) -0.67 0.50
Education (%) 0.81 0.37 0.31 0.58
 < bachelor's degree 77 23 79 21
 ≥ bachelor's degree 85 15 84 16
Relationship status (%) 0.39 0.54 0.51 0.48
 Married 81 19 82 18
 Not married 73 27 73 27
Number of children (mean, sd) 3.5 (1.5) 4.0 (1.8) -1.05 0.30 3.6 (1.5) 3.6 (1.6) 0.02 0.98
Income (%) 6.72 0.04 0.29 0.87
 <$35,000/year 67 33 80 20
 $35,000-$75,000/year 85 15 78 22
 > $75,000/year 91 9 83 17

Three themes emerged in the open-ended responses: (1) whether or not the parent believed that the child's age was a positive or negative influence on the donor's experience, (2) whether the comments indicated he effects of age were physical or emotional, and (3) the parent's beliefs about whether the effects of age had something to do with the donor child either understanding or not understanding the donation process. The following statement is a hybrid of two actual parent quotes and represents all three themes.

I guess in a way it helped her manage her feelings because she didn't fully understand or comprehend what all was going to be involved.

This quote would have been coded as (1) age effect positive, (2) effects were emotional, and (3) parent believed that the child didn't fully understand the donation process. Total percent agreement across the three coding categories was 83%-96% -- Kappa 0.69-0.84.22

We examined qualitative data by donor age group (5-7, 8-12, 13-18). See Table 2 for sample quotes for each theme by age-group. Across all age groups, parents reported that their child's age had a positive effect on donation experiences. Only 11/73 parents at 4-weeks and 6/72 at 1-year post-donation reported negative effects of age. Across all age categories, parents were more than twice as likely to mention emotional rather than physical consequences. When parents discussed emotional consequences, they often described the donation as being like an adventure for the donor, how the child's age helped him/her avoid potential fear/anxiety/stress, and the positive feelings of being able to help their ill sibling. When parents mentioned physical consequences, they often linked their child's age to being more resilient than adults, having the ability to bounce back, and to recover more quickly.

Table 2.

Examples of comments about the positive effects of age
Ages 5-7
  • “I think being young helped him to take it all in stride more. To him it was just an exciting adventure. Being young helped.” (age 6)

  • “I guess with him being younger he was more resilient, and it didn't bother him as much as maybe somebody older. He handled everything appropriately.” (age 7)

Ages 8-12
  • “He recovered real quick, he was up and around quick, someone older may have felt the aches and pains more.” (age 9)

  • “As far as I think she is a little more mature than if she was younger. Handled the stress well. Even though she was worried about her brother, I think being older she got over it pretty quick.” (age 12)

Ages 13-18
  • “Well because she's younger I think she bounced back pretty fast. Because she's younger- like a person my age would have aches and pains but because she's young and healthy she healed better.” (age 14)

  • “Being 15 at the time, she was fully aware of what she was doing and contributing. I think emotionally she was much more prepared than anyone who was a lot younger. For her, it was very rewarding. There was no fear. She was wanting to do it full-heartedly (age 15)

Examples of comments about physical and emotional effects
Ages 5-7
  • Physical: “Because she didn't really know what to expect, she didn't know it was gonna hurt so it didn't hurt.” (age 7)

  • Emotional: “He was very young, only 7 so he didn't really have that 'scared' capacity, he just knew he was helping his sister” (age 7)

Ages 8-12
  • Emotional: “Emotionally at his age he just thinks he's just helping his brother. He wasn't thinking of the medical aspects, like being put to sleep, etc. He just thought the whole thing was cool, being in the hospital, getting special treatment was cool.” (age 8)

  • Emotional: “Well because he was old enough to rationalize it and not be overly scared but was young enough to not overly think it.” (age 10)

Ages 13-18
  • Emotional: “Just cause we could explain it to him. I think he was emotionally capable of knowing what he was doing.” (age 13)

  • Physical: “In a positive way. I think he was able to recover quickly because of his age. He was just, he was happy to do it. I think mostly because he was able to recover very quickly from it.” (age 14)

Examples of comments about donor's understanding of the process
Ages 5-7
  • “I don't think she fully understood the importance or the gravity of the situation, exactly what she was doing. You know she doesn't know the difference between bone marrow and blood. I think she was, I don't know if willing would be the right word, but maybe more willing to do it because she didn't understand everything that was going to happen.” (age 6)

  • “Probably because she doesn't know much about what was going on. For that reason, I think it went smoother. If she were older, it would've been difficult.” (age 6)

Ages 8-12
  • “Because she was old enough to understand why it was worth going through that and the impact she will have from it” (age 9)

  • “If she was older, it might have been worse because she would have known more, and there would have been more fear there” (age 10)

Ages 13-18
  • “Just because at 13, they know a little more than younger children do. Like, he knew what he was doing and why he was donating. He was mentally capable of understanding that.” (age 13)

  • I think that he is old enough to understand and be able to ask the questions that he wanted to ask in order for it to be less to him. I also think that he understood it more than if he would have been a lot younger.” (age 14)

Approximately 70% of parent respondents across both post-donation time points indicated that the donors' age was linked to their ability to understand the donation process – which, in turn affected (generally positively) their donation experience. Large majorities of parents of the youngest age group (65% and >80% at the two time points) reported that their child was too young to understand the process. For the middle age group, parental respondents were almost equally split between those who thought their child understood the process (and benefitted) versus those who did not (and benefitted), and for the oldest age group, 60% and ∼90% at the two time points reported that their child understood the process.

Finally, we dichotomized PedsQL scores as above or below the at-risk cutoff and compared the groups by parents' reports of whether the child's age made a difference (yes/no) and their responses to the open-ended follow-up question. There were no significant differences in the percentage of parents who indicated that their child's age made a difference by cutoff score nor were there any obvious patterns of difference in their responses to the open-ended questions.

Our previous work indicated that ∼20% of sibling pediatric HSC donors experience poor HRQoL during and following donation, that the youngest donors appear to be most at-risk for poor HRQoL, and that parental proxy reports overestimate donor HRQoL.18 Although the question of whether poor pediatric donor HRQoL is a function of donation itself or of being part of a family with a chronically and potentially terminally ill child remains unanswered, these analyses provide additional insights about parents' beliefs about their donor child's donation experiences.

A first key conclusion is that the majority of parents (75%-80%) believed that their child's age made a difference in how they experienced the donation process. Second, parents were overwhelmingly likely to report that their child's age had a positive effect on the donation experience (85%- 90% of parents reported positive effects of age) and positive emotional effects were more often reported. Finally, 70% of parents linked their child's experience (positive or negative) to his/her ability to understand the donation process. Parents of the youngest group of donors, the group with the highest risk of poor HRQoL in our previous work, most often believed that the donation experience was positive because their child was too young to understand the process. Parents of the oldest group attributed the positive experience to their child's ability to understand. We found no quantitative or qualitative differences in how parents responded based on whether their child self-reported very poor HRQoL versus not.

Findings from this investigation are encouraging, in the sense that parents view the donation experience as generally positive for their donor children. However, they are also cautionary because they point out that some parents are unable to accurately recognize HRQoL deficits that some child donors experience around the donation/transplantation process. Ultimately, this investigation highlights the urgent need for additional investigations focused on the sources of poor HRQoL among some pediatric donors and the apparent discrepancies between parents' reports about their child's donation experiences and the child's self-reported HRQoL scores.

Acknowledgments

Funding source: Supported by a grant from the National Heart, Lung, and Blood Institute (NHLBI R01 HL085707).

Abbreviations

HSC

Hematopoietic Stem Cell

HRQoL

Health-related Quality of Life

RDSafe

RDSafe: A Multi-Institutional Study of HSC Related Donor Safety and Quality of Life

Footnotes

Financial disclosure: Dr. Varni holds the copyright and the trademark for the PedsQL™ and receives financial compensation from the Mapi Research Trust, which is a nonprofit research institute that charges distribution fees to for-profit companies that use the Pediatric Quality of Life Inventory™. There are no other potential or actual conflicts to disclose.

Manuscript preparation: This manuscript was initially drafted by Dr. Galen Switzer has not been published previously and is not under consideration elsewhere and will not be submitted elsewhere while under consideration by this journal. No honorarium, grant, or other form of payment was given to anyone to produce the manuscript.

Authorship Contributions: All authors participated in aspects of the design of the research, selection of the analytic strategy, and manuscript preparation. MAP and GES were Co-PIs on the grant and led protocol development, center recruitment, protocol oversight and management. GES and JGB collected and managed HRQoL data at the University of Pittsburgh and performed the analyses. GES, JGB, and GP analyzed the qualitative data. JGB DMK, HK, RD, RMB, RJK, MMH, and DLC facilitated and managed sampling and participant recruitment at the NMDP. All authors viewed and interpreted data, assisted with the writing and review of findings, and approved the final manuscript. Contributing authors recruited and consented study participants for the investigation.

References

  • 1.Copelan EA. Medical progress: Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–1826. doi: 10.1056/NEJMra052638. [DOI] [PubMed] [Google Scholar]
  • 2.Center for International Blood & Marrow Transplant Research. Statistical center of the Center for International Blood and Marrow Transplant Research. 2015 [Google Scholar]
  • 3.Pulsipher MA, Nagler A, Iannone R, Nelson RM. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer. 2006;46:422–433. doi: 10.1002/pbc.20708. [DOI] [PubMed] [Google Scholar]
  • 4.Pulsipher MA, Levine JE, Hayashi RJ, Chan KW, Anderson P, Duerst R, et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant. 2005;35:361–367. doi: 10.1038/sj.bmt.1704743. [DOI] [PubMed] [Google Scholar]
  • 5.Committee on Bioethics. Children as Hematopoietic Stem Cell donors. Pediatrics. 2010;125:392–404. doi: 10.1542/peds.2009-3078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bauk K, D'Auria J, Andrews A, Presler CM. The pediatric sibling donor experience in hematopoietic stem cell transplant: An integrative review of the literature. J Pediatr Nurs. 2013;28:235–242. doi: 10.1016/j.pedn.2012.09.004. [DOI] [PubMed] [Google Scholar]
  • 7.Wiener LS, Steffen-Smith E, Fry T, Wayne AS. Hematopoietic stem cell donation in children: A review of the sibling donor experience. J Psychosoc Oncol. 2007;25:45–66. doi: 10.1300/J077v25n01_03. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wiener LS, Steffen-Smith E, Battles HB, Wayne A, Love CP, Fry T. Sibling stem cell donor experiences at a single institution. Psychooncology. 2008;17:304–307. doi: 10.1002/pon.1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sobotka SA, Msall ME. The complex needs of pediatric hematopoietic stem cell donors and their families: challenges and opportunities. The Journal of Pediatrics. 2016;178:14–15. doi: 10.1016/j.jpeds.2016.08.052. epub ahead of print. [DOI] [PubMed] [Google Scholar]
  • 10.van Walraven SM, Straathof LM, Switzer GE, Lankester A, Korthof ET, Brand A, et al. Immediate and long-term somatic effects and health-related quality of life of BM donation during early childhood. A single center report in 210 pediatric donors Bone Marrow Transplant. 2013;48:40–45. doi: 10.1038/bmt.2012.102. [DOI] [PubMed] [Google Scholar]
  • 11.van Walraven SM, Ball LM, Koopman HM, Switzer GE, Ropes-de Jong CM, de Jong A, et al. Managing the dual role – experiences and coping strategies of parents donating haploidentiacal G-CSF mobilized peripheral blood stem cells to their children. Psychooncology. 2012;21:168–175. doi: 10.1002/pon.1885. [DOI] [PubMed] [Google Scholar]
  • 12.Weisz V, Robbennolt JK. Risks and benefits of pediatric bone marrow donation: A critical need for research. Behav Sci Law. 1996;14:375–391. doi: 10.1002/(SICI)1099-0798(199623)14:4<375::AID-BSL247>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  • 13.Packman W, Crittenden MR, Rieger Fischer JB, Schaffer E, Bongar B, Cowan MJ. Siblings' perceptions of the bone marrow transplantation process. J Psychosoc Oncol. 1997;15:81–105. [Google Scholar]
  • 14.Packman W, Crittenden MR, Schaeffer E, Bongar B, Fischer J, Cowan MJ. Psychosocial consequences of bone marrow transplantation in donor and nondonor siblings. J Dev Behav Pediatr. 1997;18:244–253. [PubMed] [Google Scholar]
  • 15.Kinrade LC. Preparation of sibling donor for bone marrow transplant harvest procedure. Cancer Nurs. 1987;10:77–81. [PubMed] [Google Scholar]
  • 16.MacLeod KD, Whitsett SF, Mash EJ, Pelletier W. Pediatric sibling donors of successful and unsuccessful hematopoietic stem cell transplants (HCST): A qualitative study of their psychosocial experience. J Pediatr Psycho. 2003;28:223–231. doi: 10.1093/jpepsy/jsg010. [DOI] [PubMed] [Google Scholar]
  • 17.Pentz RD, Alderfer MA, Pelletier W, Stegenga K, Haight AE, Hendershot KA, et al. Unmet needs of siblings of pediatric stem cell transplant recipients. Pediatrics. 2014;133:1156–1162. doi: 10.1542/peds.2013-3067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Wiener L, Packman W, Varni UJW, Pulsipher MA. Health-related quality of life among pediatric hematopoietic stem cell donors. Journal of Pediatrics. 2016;178:164–170. doi: 10.1016/j.jpeds.2016.07.009. epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Varni JW, Seid M, Kurtin PS. PedsQL™ 4.0: Reliability and validity of the Pediatric Quality of Life Inventory™ Version 4. 0 Generic Core Scales in healthy and patient populations Med Care. 2001;39:800–812. doi: 10.1097/00005650-200108000-00006. [DOI] [PubMed] [Google Scholar]
  • 20.Varni JW, Limbers CA, Burwinkle TM. Impaired health-related quality of life in children and adolescents with chronic conditions: A comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0. Generic Core Scales Health Qual Life Outcomes. 2007;15:1–15. doi: 10.1186/1477-7525-5-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL™ 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329–341. doi: 10.1367/1539-4409(2003)003<0329:tpaapp>2.0.co;2. [DOI] [PubMed] [Google Scholar]
  • 22.Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. [PubMed] [Google Scholar]

RESOURCES